VITEK2
Device
bioMerieux
Total Payments
$3.3M
Transactions
103
Doctors
21
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $638,744 | 79 | 19 |
| 2023 | $16,157 | 16 | 2 |
| 2021 | $5.54 | 1 | 1 |
| 2019 | $2.7M | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.3M | 65 | 99.5% |
| Consulting Fee | $9,815 | 2 | 0.3% |
| Travel and Lodging | $5,192 | 4 | 0.2% |
| Food and Beverage | $1,068 | 32 | 0.0% |
Payments by Type
Research
$3.3M
65 transactions
General
$16,075
38 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GP20 | bioMerieux | $1.0M | 0 |
| GN22 | bioMerieux | $756,382 | 0 |
| GN23 | bioMerieux | $660,767 | 0 |
| AF04 | bioMerieux | $240,206 | 0 |
| VITEK REVEAL Gram-Negative Isolate Assay | bioMerieux Inc | $207,888 | 0 |
| VITEK REVEAL EEP | bioMerieux Inc | $147,523 | 0 |
| VITEK 2 and VITEK 2 Compact SS04 Antimicrobial Susceptibility Tests | bioMerieux Inc | $143,120 | 0 |
| OUTCOME STUDIES OF RAPID IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY RESULTS WHEN COMPARED TO STANDARD OF CARE FOR PATHOGENS FROM BLOODSTREAM INFECTIONS | bioMerieux Inc | $56,450 | 0 |
| ETEST IRPA | bioMerieux Inc | $45,158 | 0 |
| VITEK 2 and VITEK 2 Compact GN24 Antimicrobial Susceptibility Tests | bioMerieux Inc | $37,569 | 0 |
| GP21 | bioMerieux | $11,117 | 0 |
| Lefamulin FDA Clinical Trial | bioMerieux Inc | $810.00 | 0 |
| Characterizing Respiratory Exacerbations in Primary Ciliary Dyskinesia | BioFire Diagnostics, LLC | $210.00 | 0 |
| SS04 | bioMerieux Inc | $57.35 | 0 |
| GN 24 | bioMerieux Inc | $45.88 | 0 |
Top Doctors Receiving Payments for VITEK2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Omaha, NE | $3.3M | 65 |
| , M.D | Internal Medicine | Omaha, NE | $7,872 | 4 |
| , M.D., PHD | Pediatric Infectious Diseases | Houston, TX | $7,418 | 7 |
| , M.D | Specialist | Miami, FL | $111.47 | 2 |
| , M.D | Internal Medicine | Salt Lake City, UT | $89.30 | 1 |
| Denver Niles | Clinical Pathology/Laboratory Medicine | Houston, TX | $86.91 | 1 |
| , MD | Infectious Disease | New Orleans, LA | $69.90 | 1 |
| , M.D | Infectious Disease | Richmond, VA | $47.79 | 2 |
| , M.D | Hematology | Bridgeport, WV | $47.79 | 2 |
| , M.D | Anatomic Pathology & Clinical Pathology | Jackson, MS | $38.83 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Dallas, TX | $36.47 | 2 |
| , MD | Anatomic Pathology & Clinical Pathology | New Orleans, LA | $30.43 | 2 |
| , M.D | Anatomic Pathology & Clinical Pathology | New Orleans, LA | $30.43 | 2 |
| , M.D | Anatomic Pathology & Clinical Pathology | Winnfield, LA | $30.43 | 2 |
| , MD | Pediatric Infectious Diseases | New Orleans, LA | $30.43 | 2 |
| , M.D | Anatomic Pathology & Clinical Pathology | Weymouth, MA | $25.32 | 1 |
| William Kasimer | Anatomic Pathology | Weymouth, MA | $25.32 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Loma Linda, CA | $23.52 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Charleston, SC | $19.64 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Milford, MA | $18.34 | 1 |
| , M.D | Hospitalist | Lynchburg, VA | $16.93 | 1 |
| , M.D | Internal Medicine | La Jolla, CA | $5.54 | 1 |
Ad
Manufacturing Companies
- bioMerieux $2.7M
- bioMerieux Inc $654,696
- BioFire Diagnostics, LLC $210.00
Product Information
- Type Device
- Total Payments $3.3M
- Total Doctors 21
- Transactions 103
About VITEK2
VITEK2 is a device associated with $3.3M in payments to 21 healthcare providers, recorded across 103 transactions in the CMS Open Payments database. The primary manufacturer is bioMerieux.
Payment data is available from 2019 to 2024. In 2024, $638,744 was paid across 79 transactions to 19 doctors.
The most common payment nature for VITEK2 is "Unspecified" ($3.3M, 99.5% of total).
VITEK2 is associated with 15 research studies, including "GP20" ($1.0M).